Cite

HARVARD Citation

    Mądry, K. et al. (2021). Low serum albumin level deteriorates prognosis in azacitidine-treated myelodysplastic syndromes patients – results of the PALG study 'PolAZA'. Hematology. 26 (1), pp. 556-564. [Online]. 
  
Back to record